The tumour suppressor protein p53 is localized in the cell nucleus where it serves to initiate cellular responses to a variety of stresses, particularly DNA damage and has the capacity to transactivate stress response genes. An emerging body of evidence indicates that its action is also exerted through direct protein ± protein interactions. An approach to understanding p53 function has been to analyse its positioning in relation to nuclear structures and we have shown that p53 can associate with the nuclear matrix. A potential nuclear matrix component for this association is actin. Here we show that p53 interacts with nuclear F-actin and we map the domains involved in this interaction. Using¯uorescence resonance energy transfer, we demonstrate that the partition of p53 between F-actin bound and unbound forms is not constant, but is modulated by the presence of DNA damage, which increases binding. Our results indicate that the dynamic interaction of p53 with the nuclear matrix has to be considered for a full understanding of the mechanisms of the p53-mediated cellular response to DNA damage.
Introduction
P53 is a tumour suppressor of major importance in human cancer. The p53 protein is constitutively expressed in normal cells and is localized within the nucleus. This nuclear localization is important for p53 to function in response to agents which induce genotoxic stress (Giaccia and Kastan, 1998; Jimenez et al., 1999) . Such agents activate p53 as a transcription factor able to orchestrate the expression of genes involved in cell growth arrest and apoptosis (for reviews see for example May and May, 1999; Ljungman, 2000) . By blocking the proliferation of damaged cells the activated p53 protein contributes towards the maintenance of genetic integrity and the suppression of tumour development (reviewed in Vogelstein et al., 2000) .
Under normal conditions of cell growth the p53 protein exists at very low levels within the nucleus and appears inactive for the transactivation of target genes (reviewed in May and May, 1999) . Although described as`latent' there is accumulating evidence that p53 in normal (non-stressed) cells may function in processes other than the transactivation of target genes. For example, p53 can be covalently attached to 5.8S rRNA (Fontoura et al., 1992) and forms ribonucleoprotein complexes with 5S rRNA, ribosomal L5 protein and hdm2 (Marechal et al., 1994) . These observations have led to the suggestion that p53 may play a role in ribosomal biogenesis (Marechal et al., 1994) . Whatever its precise function, a link between p53 and ribosomal biogenesis is consistent with the observed localization of a sub-set of p53 molecules within the nucleolus in normal cells (Rubbi and Milner, 2000) . Other potential transactivation-independent functions of p53 include DNA repair (Albrechtsen et al., 1999; Ljungman, 2000) and signal transduction involved in apoptotic pathways (Walker and Levine, 1996) .
Cell fractionation and microscopic analysis indicate distinct nuclear sub-classes of p53. In normal cells approximately half the protein is soluble in the nucleoplasm and is released following permeabilization of the nuclear membrane (Rubbi and Milner, 2000) . The residual nuclear-bound p53 is distributed between dierent nuclear sub-structures and co-localizes with transcription sites of pre-mRNA synthesis (RNA polymerase II) and of rRNA synthesis (within nucleoli, RNA polymerase I; Rubbi and Milner, 2000) . A second nucleolar sub-class of p53 is positioned at discrete sites that lie adjacent to nascent rRNA synthesis (Rubbi and Milner, 2000) . Additional foci of nuclear-bound p53 are distributed throughout the nucleus (Rubbi and Milner, 2000) .
Binding of p53 to nuclear sub-structures indicates that it can associate, directly or indirectly, with the nuclear matrix (or internal nuclear lamina). This is signi®cant since the processes of DNA replication, repair and transcription all occur at the nuclear matrix (McCready and Cook, 1984; Mullenders et al., 1988; Iborra et al., 1996; Cook, 1991) . Thus nuclear-bound p53 is physically associated with nuclear sub-structure(s) upon which the DNA-associated biochemical processes take place. Although the binding of p53 to the nuclear matrix has been described (Deppert and Haug, 1986; Rubbi and Milner, 2000; Jiang et al., 2001) , it is not clear which matrix components are bound by p53. One clue comes from the observation that treatment with RNase releases nuclear-bound p53 (Rubbi and Milner, 2000) and actin (Nakayasu and Ueda, 1985; He et al., 1990 ) from nuclei, indicating that RNA is involved, directly or indirectly, in the retention of both p53 and actin at the nuclear matrix. Since actin is a well known component of the nuclear matrix we have asked if actin is responsible for binding p53 to the nuclear matrix in normal cells. Initial studies using puri®ed proteins have already demonstrated that p53 selectively binds F-actin in vitro (Metcalfe et al., 1999) .
We have now investigated the interaction of p53 with F-actin in normal, non-stressed mammalian cells grown in culture. Using phalloidin, which binds F-actin but not G-actin, we demonstrate the presence of F-actin in the nucleus of normal, non-stressed mammalian cells. We show that cleavage of F-actin by gelsolin releases nuclear-bound p53, indicating that F-actin participates in the binding of p53 to the nuclear matrix. Fluorescent resonance energy transfer (FRET) was detected between uorescent labelled probes used to stain nuclear p53 and F-actin, thus demonstrating molecular complexing between p53 and F-actin within cells, and con®rming in vitro observations (Metcalfe et al., 1999) . Using p53 truncation constructs we have mapped the binding of Factin to the C-terminus of p53. We show that modulation of this domain by mimicking the phosphorylation of the C-terminal Ser392 amino acid residue results in increased binding between p53 and F-actin in vitro.
The central core domain of p53 also in¯uenced its molecular association with F-actin, and cancer-derived p53 mutants exhibit reduced F-actin binding. P53 is a major player in the cellular response to DNA damage and here we show that the binding of wild type p53 to nuclear F-actin increases following DNA damage (induced by UV irradiation). The eect appears speci®c for DNA damage since drug-induced activation of p53 (in the absence of DNA damage) did not increase p53/ F-actin association. Our results thus demonstrate that a nuclear sub-set of p53 is attached to the nuclear matrix via F-actin and that this molecular interaction is dynamic and modulated in response to DNA damage.
Results
For this study four cell lines were used: murine 3T3 cells and human Hep G2, LS174T and SW48 cell lines (see Materials and methods). Similar results were obtained for all cell lines. In some experiments the cells were permeabilized before ®xation (Rubbi and Milner, 2000) in order to release soluble nuclear p53 and observe nuclear-bound p53. Figures represent confocal sections of individual nuclei unless otherwise stated.
Involvement of F-actin in the nuclear binding of p53
To study the putative binding of p53 to nuclear F-actin we ®rst compared the nuclear distribution of both molecules. A confocal section of a murine 3T3 cell stained with TRITC-labelled phalloidin, which binds ®lamentous but not monomeric actin, revealed that Factin is distributed more or less uniformly throughout the cell nucleus ( Figure 1a ). Negative controls with uorochrome only showed no staining (data not shown). Identical results were observed in all four cell lines studied. P53 was detected using antibodies against its N-terminal region, PAb242 for murine p53 and DO-1 for human p53. Overlapping of the p53 image (green) showed that p53 is present in nuclear F-actin rich regions (red), with a punctate staining which is characteristic for p53 in normal, non-stressed cells (Figure 1a' ). Nuclear actin was also evidenced by an anti-actin mouse monoclonal antibody (Figure 1b ) which detects total actin, i.e. is not speci®c for F-actin. In this particular case, p53 was detected using a goat polyclonal antibody, in order to allow for dual labelling with the anti-actin mouse antibody. Although both nuclear and cytoplasmic staining patterns for total actin were slightly dierent from F-actin, overlapping between antibody-stained actin and p53 was observable in the cell nucleus (Figure 1b' ).
To study the nuclear binding of p53 cells were permeabilized before ®xation, where soluble p53 is released and nuclear-bound p53 can be detected (Figure 2a,a' ). Hep G2 human hepatoma cells were employed, since in contrast to 3T3 cells, these cells are more eciently retained on coverslips during permeabilization. To ask if F-actin participates in the nuclear retention of p53 the F-actin depolymerizing enzyme gelsolin was added during permeabilization. When compared with untreated nuclei (Figure 2a ), the level of nuclear-bound p53 was dramatically decreased by gelsolin treatment (Figure 2b ). Thus, F-actin appears to play a role in the nuclear attachment of p53. The corresponding Nomarski images indicated that the gelsolin treatment left the overall nuclear structure intact (Figure 2a' ,b').
Nuclear p53 and F-actin are located at protein ± protein interaction distance
To determine if p53 directly interacts with F-actin we used FRET analysis. We used the same p53 and F-actin labelling scheme of Figure 1 , consisting of an anti-p53 antibody in combination with either directly-labelled anti-actin antibody or phalloidin. The occurrence of FRET between p53-bound FITC (or its derivative dtFITC) and F-actin-bound TRITC or Cy3 was explored using the acceptor photobleaching method of Bastiaens et al. (1996) (see Materials and methods). Since the pairs FITC/TRITC and FITC/Cy3 have R 0 values (distance of 50% FRET eciency) of approximately 55A Ê and 56A Ê (Haugland, 1996; Jares-Erijman and Jovin, 1996) , detection of a FRET signal between these¯uorochromes would indicate that the molecules to which they are attached are located at distances compatible with a direct molecular interaction.
Superimposed red and green images of F-actin and p53 (R 1 and G 1 , respectively ± see Materials and methods), acquired for FRET analysis in 3T3 cells are shown in Figure 3a ,b. Measurements of FRET eciencies after acceptor photobleaching, represented both as pseudo-colour images (Figure 3a ',b') and as histograms ( Figure 3a '',b''), demonstrate the existence of energy transfer between p53-associated FITC and Factin-associated TRITC. This was revealed by the shift to the red in the photobleached area (boxed) of pseudo-colour images a' and b' and to the right in the red lines of histograms a'' and b'', as compared with unbleached areas (see Figure 3 legend). When p53 was detected with secondary antibody-FITC the measured FRET eciencies were increased as expected for the shorter inter-¯uorochrome distances (Figure 3b, b', b'') . This con®rmed that the FRET eciencies measured were sensitive to inter-¯uorochrome distance.
A similar eect was obtained when instead of phalloidin we used a Cy3-labelled anti-actin monoclonal antibody (Figure 3c ,c',c''). FRET eciency was lower compared to phalloidin labelling due to the additional distance brought in by the anti-actin antibody (Figure 3c ''). As a control, the FRET analysis for cyclin E and phalloidin-labelled F-actin showed no energy transfer between FITC and TRITC (Figure 3d, d', d'') . This demonstrates that the FRET observed between F-actin and p53 is speci®c and is not a general property of nuclear antigens.
The calculated FRET eciencies corresponded to an inter-¯uorochrome distance of 6 ± 7 nm, which indicates that p53 and F-actin were located within a protein ± protein interaction distance of 556 nm. We conclude that F-actin-dependent anchoring of p53 within the nucleus re¯ects direct interaction between p53 and F-actin.
p53 domains involved in interaction with F-actin
We next asked which domain(s) of p53 participate in the interaction with F-actin and which would be available for simultaneous interaction with other macromolecules, in particular with damaged DNA. Using similar experimental conditions to those previously employed to demonstrate in vitro binding between p53 and F-actin (Metcalfe et al., 1999) we ®rst sought to identify the domain(s) of p53 required for interaction with F-actin. For this purpose we compared a series of human and murine p53 constructs either full length or carrying truncations at the amino and/or carboxyl termini (detailed in Figure 4a,b) . In vitro translated and radiolabelled p53 derivatives were incubated with puri®ed F-actin and complexes were immunoprecipitated using an anti-actin monoclonal antibody. The percentages of input p53 bound to F-actin are represented in Figure 4b . There was no signi®cant dierence in F-actin binding between human and murine wild type p53, with bound percentages comprising about 50% of total input p53 in both cases. Comparison of p53-F-actin binding by various deletion mutants of p53 revealed that the deletion of the last 30 aminoacid residues from the C-terminus dramatically reduces p53 binding to F-actin ( Figure 4b ) suggesting a direct involvement of this domain in the interaction with F-actin.
The carboxy terminus of p53 is subject to posttranslational modi®cation via phosphorylation (reviewed in Meek, 1999) . We therefore analysed the binding to F-actin of mutants of p53 which mimic phosphorylation by substituting target serine amino acid residues at positions 376, 378 and 392 to aspartic acid to simulate a negative charge, or as a control, to alanine. We analysed the input percentages of phosphorylation-mimicking mutants of p53 bound to Factin and found that there were no dierence in F-actin binding when residues 376 or 378 were mutated to either aspartic acid or alanine (Figure 4c ). Double mutation at residues 376 and 378 to aspartic acid also failed to produce any dierence. However, comparison between mutants resulting from substitution of Ser392 showed that mimicking phosphorylation at this site (Ser392Asp) increased binding to F-actin relative to wt p53 and p53 Ser392Ala (Figure 4c ). These data suggest that modulation of the p53-F-actin interaction may be achieved by phosphorylation of serine 392.
The carboxy terminus of p53 is involved in nonsequence speci®c binding of DNA (see Introduction) and we next asked if p53 can simultaneously bind Factin and non-speci®c DNA. For this purpose we used a double stranded oligonucleotide containing three insertion-deletions (L-DNA). The oligonucleotide representing damaged DNA was coupled to magnetic beads for easy separation of DNA-bound p53. When wt murine p53 was pre-incubated with a saturating amount of F-actin before incubation with L-DNAcoated magnetic beads we did not observe any decrease in the amount of bound p53 (Figure 4d, left panel) . In fact, there was a slight increase in the amount of p53 pulled down with magnetic beads, which suggests that p53-decorated F-actin ®laments might be bound to L-DNA through a linking p53 molecule. This was con®rmed by analysing similar samples by immunoblotting analysis for the presence of F-actin in p53-DNA complexes. Hardly any F-actin was detectable in pull down fractions on the L-DNA-coated magnetic beads (Figure 4d, right panel, left lane) . However, when F-actin was preincubated with p53 we observed a signi®cant amount of actin pulled down with beads ( Figure 4d , right panel, right lane). The data therefore suggest that p53 has the capacity for simultaneous binding of both F-actin and DNA containing insertiondeletion mismatches.
Binding to F-actin is reduced for cancer-associated mutants of p53
We also tested three mutants of p53 for binding to Factin in vitro. The mutants included p53R248H, which retains overall wild type conformation, but is unable to . To reveal the weak nuclear F-actin signal, the intensity was scaled such that the more intense cytoplasmic signal appears oversaturated. (c) Identical analysis for a Hep G2 cell stained with a Cy3-labelled anti-actin monoclonal antibody and with an anti-p53 polyclonal antibody followed by a FITC-labelled secondary antibody. Bar: 5 mm. (a'), (b') and (c') are pseudo-colour images of FRET eciencies between p53-linked FITC (or dtFITC) and F-actin-linked TRITC or Cy3 calculated after photobleaching of the acceptor (TRITC or Cy3). Photobleaching was performed over the marked region using the 543 nm line of a HeNe laser. The colour scale is a reference for FRET eciencies. (a''), (b'') and (c''): corresponding histograms showing FRET eciencies (red lines; bleached area) shifted to the right with respect to the black lines (unbleached areas) where theoretically G 1 =G 2 (see Eq. 1, Materials and methods). S-labelled p53 alone, or pre-incubated with F-actin, was incubated with L-DNA coated magnetic beads (Materials and methods). DNA bound fractions were analysed by 15% SDS ± PAGE followed by autoradiography. Right panel shows an immunoblot of samples of actin bound to L-DNA alone (DNA+F-actin) or to complex of p53/L-DNA (DNA+mp53+F-actin), after 15% SDS ± PAGE and probing with anti-actin antibody interact with sequence-speci®c DNA-targets of p53, and two of the most frequent p53 mutants in human cancer which exhibit either abnormal conformation (R175H) or inability to interact with the p53 consensus site (R273H) (Cho et al., 1994) . All three p53 mutants showed a reduction in F-actin binding relative to wild type (Figure 5c ), with amounts of radiolabelled protein associated with F-actin decreased twofold for R248H and R175H mutants and ®vefold for the R273H mutant. This indicates that the interaction between p53 and F-actin not only requires C-terminal domain of p53, but also involves the central core domain of p53 and may be disrupted either by substitution of a speci®c surface residue (e.g. R248) or changes in the overall folding of p53.
These in vitro observations were con®rmed in vivo for the R248W mutant of p53. Here we used the human colon carcinoma cell lines LS174T and SW48, expressing similar levels of wild type and R248W p53, respectively (our unpublished observations). Comparison of the FRET eciencies between p53-and F-actin-attached uorochromes demonstrated that the average FRET eciency between F-actin and the R248W mutant was reduced relative to wild type p53 (Figure 5b ). We consider that this reduction is due to a lower proportion of p53 molecules engaged in F-actin interaction. This indicates that the interaction between p53 and F-actin in vivo can be reduced in a mutant p53 protein as predicted by the in vitro observations. Furthermore, it shows that FRET analysis is capable of revealing dierences in p53-F-actin interaction in vivo.
p53 binding to F-actin is increased by DNA damage
Having demonstrated that p53 has the capacity to bind both F-actin and damaged DNA simultaneously (Figure 4d ) we next asked if DNA damage aects the association between p53 and F-actin in vivo. For this purpose we analysed p53 binding to F-actin in cells before and after exposure to UV irradiation. The FRET eciencies between p53-and F-actin-linked uorochromes 4 h after UV irradiation at 40 J/m 2 ( Figure 6a,a' ,c,c') were consistently higher than in unirradiated cells (Figure 6b,b',d,d') . Similar results were obtained by treatment with cisplatin which causes DNA damage in form of bulky DNA adducts (data not shown). The observed increase in FRET eciency after UV irradiation may be due to either (i) shortened distance between p53 and F-actin or (ii) more p53 molecules engaged in interaction with F-actin or vice versa. Since the¯uorochromes are not directly attached to p53 and F-actin but are spaced by antibodies, it is unlikely that any shortening of the p53/F-actin interaction distance would cause detectable changes in the FRET signal. We therefore consider that more p53 molecules are engaged in F-actin interaction after UV irradiation. Treatment with CK2 and cdk7 inhibitor 5,6-dichloro-1-b-D ribofuranosylbenzimidazole (DRB), which induces p53 without DNA damage (Andera and Wasylyk, 1997) , had either no eect on the FRET eciency between p53 and F-actin or diminished it. This is shown in Figure 7 , where the nuclei of 3T3 cells Figure 6 The association between p53/F-actin is increased by DNA damage. 3T3 cells were irradiated with UV light (254 nm) at 40 J/m 2 , incubated for 4 h, ®xed, double labelled for p53 with PAb242 antibody, followed by biotinylated secondary antibody/ dtFITC-streptavidin and F-actin using TRITC-phalloidin, and analysed for FRET. Pseudo-color images and eciency histograms were generated as in Figure 3 . (a) and (a'): p53/F-actin FRET in two UV-irradiated 3T3 nuclei; (b) and (b'): control non-irradiated 3T3 nuclei. (c), (c'), (d) and (d') are the corresponding FRET eciency histograms. The FITC-TRITC energy transfer is more ecient after DNA damage, as revealed by the shift to the red in pseudo-color images (a) and (a') and to the right in the red lines of histograms (c) and (c'), as compared with control images (b) and (b') and histograms (d) and (d') treated with 100 mM DRB for 2 h (Figure 7a,a' ,c,c') and untreated (Figure 7b,b',d,d' ) are compared. This indicates that the apparent increase in p53/F-actin interaction observed following UV irradiation is not due to p53 accumulation but is directly dependent upon the presence of DNA damage. The reduction in FRET eciency after DRB treatment correlates with the increased levels of p53, which are already notice- Figure 7 DNA damage-independent activation of p53 does not increase F-actin binding. 3T3 cells were incubated for 2 h with 100 mM DRB and analysed for FRET between p53-and F-actin-linked¯uorochromes exactly as in Figure 6 able within 2 h of DRB treatment. Taken together, these data indicate that p53 and F-actin are not bound at a constant ratio, but this binding ratio can be modulated according to cell stresses.
Discussion
Binding to the nuclear matrix appears to be a general property of transcription factors and other nuclear proteins (Pederson, 1998) . However, the physiological role(s) of these associations is not always clear. Nevertheless, for some of these proteins the partition between free and nuclear matrix-bound forms has been shown to be physiologically modulated (Mancini et al., 1994; Pederson, 1998) and it has been proposed that this modulation of the partition is crucial to their function.
Here we demonstrate that nuclear F-actin participates in the nuclear matrix binding of p53. More importantly, we show that the partition between Factin bound and unbound forms is not constant, but is modulated by the presence of DNA damage. The activation of p53 itself does not appear to be a requirement for increased F-actin binding, as demonstrated by the lack of increase in FRET eciency after DRB treatment (Figure 7) .
It is interesting that p53 binds a protein which is abundant throughout the cell nucleus (see Figure 1) . In addition to its transcriptional activation capabilities, p53 is likely to be involved in other nuclear processes such as DNA repair (Albrechtsen et al., 1999; Ljungman, 2000; Rubbi and Milner, 2000) . Since all of these processes occur in nuclear-matrix associated`factories', the existence of a nuclear matrix-bound form of p53 is no surprise. In addition, the observations reported here that DNA damage is a modulator of the F-actin binding of p53 suggest that nuclear matrix binding may be a means of modulating the participation of p53 in such processes. Actin has been demonstrated to be associated with transcription sites (Nguyen et al., 1998) and with nascent RNA (Nakayasu and Ueda, 1985) and we have shown that p53 is co-localized with transcription sites (Rubbi and Milner, 2000) .
Our data are also in agreement with the proposed involvement of p53 in nuclear processes that can arise at a variety of nuclear locations (e.g. global DNA repair). P53 can interact with a wide range of proteins involved in transcription and DNA repair, such as XPD and XPB helicases (Wang et al., 1995; LeÂ veillard et al., 1996) , RPA (Dutta et al., 1993) , TFIIH cdk7 complex (Lu et al., 1997; Ko et al., 1997) and CSB (Wang et al., 1995) . In addition, p53 can also bind single-stranded DNA (Oberosler et al., 1993; Bakalkin et al., 1995) and mismatches (Lee et al., 1995; Szak and Pietenpol, 1999) . It is therefore conceivable that p53 might participate in the assembly of DNA repair complexes in global genome repair and/or in the remodelling of transcription sites into transcriptioncoupled repair sites. This would also be in agreement with our data that modulation of the carboxy-terminus of p53 by mimicking its phosphorylation enhances its binding to F-actin in vitro. Residue Ser392 is phosphorylated by casein kinase 2 (CK2) in vivo in response to DNA damage produced by UV-light (reviewed in Meek, 1999) . It is therefore plausible to suggest that, apart from increasing speci®c DNA binding, phosphorylation at Ser392 may also enhance p53 binding to nuclear F-actin. Overall our results indicate that the transcriptional (and/or DNA repair) abilities of p53 may depend not only on its binding to DNA and components of transcription/repair machineries, but also on its interaction with scaolding structures within the nucleus.
Materials and methods

Cell cultures
Murine NIH 3T3, Hep G2 (human hepatoma cells expressing normal levels of wt p53 ± MuÈ ller et al., 1997) and LS174T (human colon carcinoma expressing wt p53) were cultured in DMEM + 10% FCS. SW48 cells (human colon carcinoma expressing R248W mtp53) were cultured in RPMI 1640 + 10% FCS. For microscopy 1 ± 3610 4 cells were seeded onto 13 mm diameter coverslips in 24-well plates. For DRB treatment, 100 mM DRB (Sigma) was added to the medium. For irradiation, cells were washed with PBS and exposed to UV-C at 40 J/m 2 , and returned to culture medium for the speci®ed times.
Cell permeabilization and fixation
Coverslips were washed twice with TBS, and sequentially covered with 150 ml of gelsolin digestion buer (GB) (Rabinovitz and Mercurio, 1997; 0.15 m NaCl, 10 mm Tris, 1 mm MgCl 2 , 0.2 mm DTT, 0.5 mm CaCl 2 , 25% glycerol, pH 8.0) for 4 ± 5 min; 150 ml GB+0.5% Triton X-100 for 3.5 min; 150 ml GB for 30 min at 378C with or without 0.4 mM gelsolin (Sigma). Next, cells were washed once with TBS and ®xed. For wide-®eld¯uorescence cells were ®xed with cold methanol for 30 min, dipped in cold acetone and transferred to PBS-T (PBS+0.2% Tween 20). For confocal microscopy cells were ®xed with 4% paraformaldehyde for 15 min and washed with PBS-T.
Immunostaining
Fixed cells were blocked in PBS-T-S (PBS-T + 10% normal serum of the same species of the secondary antibody) for 20 min. All antibodies were diluted in PBS-T-S. DO-1 antibody (mouse anti-human p53 ± Oncogene BioScience) and rabbit anti-cyclin E (SantaCruz) were diluted 1:100; PAb242 antibody (mouse anti-mouse p53) was used as undiluted hybridoma supernatant; Cy3-labelled anti-actin antibody (clone AC-40, Sigma) was diluted 1:50; goat antip53 (C19, Santa Cruz) was diluted 1:100 and used only for dual staining with the anti-actin mouse monoclonal antibody. Biotinylated donkey anti-mouse IgG (Jackson ImmunoResearch); FITC-rabbit anti-mouse IgG (Dako) and FITCswine anti-rabbit (Dako) were used 1:100. Biotin was detected using streptavidin conjugated with dichlorotriazinylaminouorescein (dtFITC) which is spectrally identical to FITC (Jackson ImmunoResearch). Coverslips were incubated on 20 ml drops of antibody on para®lm, for 1 h at RT or overnight at 48C in humid chamber, with four 2 min washings in PBS-T. For F-actin detection, 50 mg/ml TRITC-phalloidin (Sigma) were added to the last antibody. For FRET analysis, samples were mounted in Crystal/Mount (Biomeda); otherwise a Mowiol 4-88-based medium with 100 mg/ml DABCO was used. In FRET experiments, although detection of p53 FITC-labelled secondary antibody detection produced higher eciencies (due to shorter distances) than biotinylated secondary antibody plus dtFITC-streptavidin, the higher¯uorescence obtained with the latter resulted in histograms of better quality and was used.
Microscopy analyses
For wide-®eld¯uorescence either a 663 or a 640 oil immersion objective (Carl Zeiss) was used. For confocal microscopy we used a LSM 410 system (Carl Zeiss) equipped with Ar ion and He/Ne lasers and a 663 1.4NA PlanApochromatic objective.
FRET analysis was performed by acceptor photobleaching as described by Bastiaens et al. (1996) . Red images (TRITC) were acquired with the 543 nm line of a 5 mW He/Ne laser with a 10% ND ®lter and normal rate (2.1 msec-line). Bleaching was performed over 2566128 pixel regions by removing the ND ®lter and scanning at a slow rate (0.25 sec/line). The acquisition sequence was: R 1 (®rst red image), G 1 (®rst green image), bleaching, G 2 and R 2 . Noise was reduced with a 363 low-pass ®lter and G 1 and G 2 images were aligned visually. Threshold values were selected to eliminate background and FRET eciencies were calculated as: E=17G 1 /G 2 (Equation 1). Measured eciencies were expressed as pseudo-color images or as histograms (see Figure 3) . The relationship between interuorochrome (R) distances and measured eciencies (E) was calculated as follows: E 1 1 À RaR 0 6 1 where R 0 is the distance of 50% eciency.
p53 ± F-actin and p53-DNA binding in vitro p53 proteins were constructed and produced by translation in vitro using rabbit reticulocyte lysate (Promega), [ 35 S]-methionine radio-label and plasmids encoding wild type human p53, murine p53 or its derivatives under the SP6 or T7 promoters, as described in Okorokov and Milner (1999) . F-actin preparation was performed as described in Metcalfe et al. (1999) . For p53 binding to F-actin assay equal amounts of radiolabelled p53 were incubated with 10 pmol of F-actin for 20 min at room temperature in binding buer (20 mm Tris-HCl, pH 7.5; 150 mm NaCl; 0.1% NP40; 10% glycerol; 5 mm DTT). The p53-F-actin complexes were pulled down by immunoprecipitation with anti-actin monoclonal antibody (Sigma) and analysed by scintillation counting. Data of four experiments were normalized with respect to the initial input of radiolabelled protein. P53 binding to biotinylated oligonucleotides was performed as described in Okorokov and Milner, 1999 . When complexes of p53 and F-actin were analysed for DNA binding, in vitro produced p53 was preincubated with 50 pmol of F-actin for 20 min at room temperature and then added to the DNA-coated magnetic beads. Proteins retained on the beads after harvesting and repeated washing were analysed by 15% SDS ± PAGE followed by autoradiography (for radiolabelled p53) or by immunoblotting (for actin).
